Concerning the relationships between genes, risk factors and immunity in Alzheimer's disease, Autism, Bipolar disorder , multiple sclerosis, Parkinson's disease, schizophrenia and chronic fatigue
Pharmacogenomics will allow the use of personalised medicine tailored to the individual's genes that can help decide whether a drug will be effective or toxic.
No comments:
Post a Comment